Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, at its meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Johnson Pharmacare Ltd (formerly Sun and Shine Worldwide Limited), at its meeting held on 24th November 2025, approved the setting up of a new Corporate Office at 1002, 10th Floor, Vikram Tower, Rajendra Place, New Delhi-110060. The new office will handle centralised management, administration, and operational functions of the company. Director Umesh Kumar has been authorised to finalise lease agreements, execute necessary documents, and oversee the setup. The board meeting lasted from 5:00 PM to 5:30 PM.
This is an administrative relocation/setup and does not directly impact revenue or operations. Shareholders should note the company's shift of corporate base to Delhi, which may help with operational efficiency but is unlikely to materially move the stock price.